Vireo Growth (VREOF) Accumulated Expenses (2020 - 2026)
Vireo Growth's (VREOF) quarterly Accumulated Expenses came in at $33.3 million in Q1 2026, up 667.11% year-on-year from $4.3 million in Q1 2025, and up 25.19% quarter-over-quarter from $26.6 million in Q4 2025.
Vireo Growth (VREOF) Accumulated Expenses (2020 - 2026) Analysis & Trends
Vireo Growth has disclosed Accumulated Expenses across 7 years of filings, most recently posting $33.3 million for Q1 2026.
- Accumulated Expenses for Q1 2026 came in at $33.3 million, up 667.11% year-over-year; the trailing twelve-month figure through Mar 2026 was $33.3 million (up 667.11% YoY), and the FY2025 annual result was $26.6 million, up 288.9% from the prior year.
- Accumulated Expenses came in at $33.3 million for Q1 2026 at Vireo Growth, up from $26.6 million in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $33.3 million in Q1 2026 to a low of $4.3 million in Q3 2024.
- The 5-year median for Accumulated Expenses is $7.4 million (2022), against an average of $11.4 million.
- Across the five-year window, Accumulated Expenses tumbled 77.14% in 2024 and soared 667.11% in 2026, its largest moves.
- Vireo Growth's Accumulated Expenses stood at $6.2 million in 2022, then retreated by 21.39% to $4.9 million in 2023, then soared by 40.95% to $6.8 million in 2024, then surged by 288.9% to $26.6 million in 2025, then increased by 25.19% to $33.3 million in 2026.
- The last three Accumulated Expenses figures came in at $33.3 million (Q1 2026), $26.6 million (Q4 2025), and $17.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Vireo Growth | - | - | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33.30 Mn |
| Dec 31, 2025 | 26.60 Mn |
| Sep 30, 2025 | 17.76 Mn |
| Jun 30, 2025 | 17.39 Mn |
| Mar 31, 2025 | 4.34 Mn |
| Dec 31, 2024 | 6.84 Mn |
| Sep 30, 2024 | 4.30 Mn |
| Jun 30, 2024 | 4.39 Mn |
| Mar 31, 2024 | 4.63 Mn |
| Dec 31, 2023 | 4.85 Mn |
| Sep 30, 2023 | 18.80 Mn |
| Jun 30, 2023 | 15.73 Mn |
| Mar 31, 2023 | 5.31 Mn |
| Dec 31, 2022 | 6.17 Mn |
| Sep 30, 2022 | 7.37 Mn |
| Jun 30, 2022 | 7.91 Mn |
| Mar 31, 2022 | 7.62 Mn |
| Dec 31, 2021 | 7.71 Mn |
| Sep 30, 2021 | 3.62 Mn |
| Jun 30, 2021 | 5.61 Mn |